Skip to main content
53 search results for:

ADA 2019 

sort by |
"newest" sorts results by publication date. "most relevant" also considers factors like how often the search phrase is in the result.
  1. 10-09-2019 | Diet | Editorial | Article

    Nutrition therapy for diabetes: A marathon, not a sprint

    What's new in the 2019 update to the ADA guidelines on nutrition therapy for adults with diabetes or prediabetes? Diabetes Educator Amy Hess Fischl explains.

  2. 18-06-2019 | Hypoglycemia | ADA 2019 | Article

    High-intensity exercise may trigger hypoglycemia counterregulatory response

    Research presented at the 79th ADA Scientific Sessions in San Francisco, California, USA, suggests that high-intensity exercise can partially restore counterregulatory responses to hypoglycemia in people with impaired awareness of the condition.

  3. 27-06-2021 | ADA 2021 | News | Article

    Early initiation of CGM may improve glycemic control in youth with type 1 diabetes

    Prahalad noted that the 4T study participants who were diagnosed between March 2019 and May 2020 were offered weekly remote monitoring with a CGM care team, and an additional study presented as a poster compared glycemic outcomes in those patients who took up the offer with those given CGM alone.

  4. 06-07-2021 | ADA 2021 | News | Article

    Hyperglycemia, renal dysfunction linked to amputations in type 1 diabetes

    Overall, the standardized incidence of amputations declined over the study period, from 1998 to 2019, and this was the case for both major and minor amputations.

  5. 01-04-2022 | DUKPC 2022 | News | Article

    CVD-focused SGLT2 inhibitor prescribing failing to take hold

    In 2018, the ADA/EASD consensus statement was published, placing SGLT2 inhibitors as a priority second-line (after metformin) glucose-lowering option for people with established CVD, particularly those with heart failure or kidney disease.

  6. 16-06-2020 | ADA 2020 | Conference coverage | Article

    Glycemic control not improving in youth and young adults with diabetes

    In this group, mean HbA1c was 7.9% (63 mmol/mol) in 2008–2013, increasing to 10.0% (86 mmol/mol) in 2014–2019.

  7. 04-03-2019 | Mental health | Editorial | Article

    Diabetes and dementia: Addressing the needs of an overlooked population

    Some larger societies such as the ADA and  IDF have specific sections of guidance covering dementia; however, in the UK there is no specific guidance.

  8. 19-06-2019 | Diet | ADA 2019 | Article

    DiRECT: Beta cells ‘not dead’ in type 2 diabetes

    By Eleanor McDermid medwireNews is an independent medical news service provided by Springer Healthcare. © 2019 Springer Healthcare part of the Springer Nature group ADA 2019; San Francisco, California, USA: 7–11 June More on this topic News story | Diabetes remission durable for a third of DiRECT participants Expert comment | WATCH: Roy Taylor discusses the 2-year DiRECT results Expert comment | WATCH: Obesity specialist John Wilding reflects on the 2-year DiRECT outcomes

  9. 13-06-2020 | ADA 2020 | Conference coverage | Article

    Telehealth delivers improved type 2 diabetes control in real-world care

    She reported that the study “successfully engaged” 125 people with type 2 diabetes across five sites between 2017 and 2019, representing 30–100% of eligible people.

  10. 13-06-2020 | ADA 2020 | Conference coverage | Article

    Researchers identify factors associated with negative psychologic impact of diabetes

    Speaking at the virtual ADA 80th Scientific Sessions, Soren Skovlund (Aalborg University) said that 8918 people with diabetes took part in the Life with Diabetes 2019 online survey, and the present analysis focused on psychologic impact, access to support and care, and wishes for improvement.

  11. 09-06-2019 | Insulin degludec/Liraglutide | ADA 2019 | Article

    IDegLira delays need for treatment intensification over glargine

    By Eleanor McDermid medwireNews is an independent medical news service provided by Springer Healthcare. © 2019 Springer Healthcare part of the Springer Nature group Lancet Diabetes Endocrinol 2019; doi:10.1016/ S2213-8587(19)30184-6 Lancet Diabetes Endocrinol 2019; doi:10.1016/S2213-8587(19)30198-6 79th ADA Scientific Sessions; San Francisco, California, USA: 7–11 June 2019 More on this topic News story |  Support for add-on IDegLira in SGLT2 inhibitor-treated type 2 diabetes News story |  Real-world data confirm benefits of IDegLira ​​​​​​​

  12. 10-06-2019 | Adolescents | News | Article

    Shared medical appointments improve psychosocial outcomes in young diabetes

    Shared medical appointments may help adolescents with type 1 diabetes to reduce family conflict and improve their depressive symptoms, show data presented at the 79th ADA Scientific Sessions in San Francisco, California, USA.

  13. 09-06-2019 | Semaglutide | ADA 2019 | Article

    PIONEER 2, PIONEER 4 show benefits of oral semaglutide in type 2 diabetes

    By Laura Cowen medwireNews is an independent medical news service provided by Springer Healthcare. © 2019 Springer Healthcare part of the Springer Nature group Diabetes 2019; doi:10.2337/db19-54-OR Lancet 2019; doi:10.1016/S0140-6736(19)31271-1 Lancet 2019; doi: 10.1016/S0140-6736(19)31350-9 79th ADA Scientific Sessions; San Francisco, California, USA: 7–11 June 2019 More on this topic News story |  PIONEER 3: Oral semaglutide proves worth against sitagliptin News story |  Promising phase II results for oral semaglutide ​​​​​​​

  14. 25-06-2019 | Hypertension | ADA 2019 | Article

    Stricter BP thresholds may be needed in type 1 diabetes

    By Eleanor McDermid medwireNews is an independent medical news service provided by Springer Healthcare. © 2019 Springer Healthcare part of the Springer Nature group ADA Scientific Sessions, San Francisco, California, USA: 7–11 June 2019 More on this topic News story | Masked hypertension common in type 1 diabetes patients News story | Modifiable cardiometabolic risk factors dominant in type 1 diabetes mortality risk News story | Low BP could be renoprotective in type 1 diabetes Ask the expert | WATCH: Jay Shubrook asks Ian de Boer about current advice on managing BP in people with diabetes

  15. 10-06-2019 | Dulaglutide | ADA 2019 | Article

    Dulaglutide cardioprotective in relatively low-risk REWIND population

    By Eleanor McDermid medwireNews is an independent medical news service provided by Springer Healthcare. © 2019 Springer Healthcare part of the Springer Nature group Lancet 2019; doi:10.1016/S0140-6736(19)31149-3 Lancet 2019; doi:10.1016/S0140-6736(19)31150-X Lancet 2019; doi:10.1016/S0140-6736(19)31267-X 79th ADA Scientific Sessions; San Francisco, California, USA: 7–11 June 2019

  16. 09-06-2019 | Semaglutide | ADA 2019 | Article

    PIONEER trials test oral semaglutide in moderate renal impairment, flexible dosing

    By Eleanor McDermid medwireNews is an independent medical news service provided by Springer Healthcare. © 2019 Springer Healthcare part of the Springer Nature group Lancet Diabetes Endocrinol 2019; doi:10.1016/S2213-8587(19)30192-5 (PIONEER 5) Lancet Diabetes Endocrinol 2019; doi:10.1016/S2213-8587(19)30194-9 (PIONEER 7) Lancet Diabetes Endocrinol 2019; doi:10.1016/S2213-8587(19)30182-2 (commentary) 79th ADA Scientific Sessions; San Francisco, California, USA: 7–11 June 2019 More on this topic News story |  PIONEER 3: Oral semaglutide proves worth against sitagliptin News story |  PIONEER 2, PIONEER 4 show benefits of oral semaglutide in type 2 diabetes ​​​​​​​

  17. 12-06-2019 | Canagliflozin | News | Article

    Canagliflozin benefits span multiple cardiovascular backgrounds

    By Laura Cowen medwireNews is an independent medical news service provided by Springer Healthcare. © 2019 Springer Healthcare part of the Springer Nature group 79th ADA Scientific Sessions; San Francisco, California, USA: 7–11 June 2019 More on this topic News story | Canagliflozin may offer renal protection in people with type 2 diabetes and CKD News story | Canagliflozin may reduce HF events irrespective of ejection fraction ​​​​​​​

  18. 12-06-2019 | DPP-4 inhibitors | News | Article

    CARMELINA findings confirmed in highest CV risk subgroups

    Secondary data from the CARMELINA trial, presented at the 79th ADA Scientific Sessions in San Francisco, California, USA, confirm the positive primary cardiovascular and renal safety findings, this time in particularly high-risk patients.

  19. 11-06-2019 | Glucagon | News | Article

    Phase III data support dasiglucagon use for severe hypoglycemia

    Dasiglucagon has potential as a fast, effective treatment for severe hypoglycemia in patients with type 1 diabetes, show phase III study data presented at the 79th ADA Scientific Sessions in San Francisco, California, USA.

  20. 09-06-2019 | Pathophysiology | News | Article

    Multiple autoantibody non-maintenance may reduce diabetes progression risk

    Although a rare occurrence, non-maintenance of two or more type 1 diabetes autoantibodies may be associated with a reduced risk for progression to diabetes, show data presented at the 79th ADA Scientific Sessions in San Francisco, California, USA.

Filter search results

Search Operators:

„ ... ... “ Finds documents with exactly this word group, in exactly this word order and spelling (e.g., "employer branding").
AND Finds documents with both search terms (e.g., sales AND bonus).
OR Finds documents with one or the other search term (e.g., porsche OR volkswagen).
Blank Space Finds documents with all search terms. Blank space is understood as AND (e.g., man robot production).
NOT Finds documents with no appearance of the word behind NOT (e.g., ford NOT "harrison ford").
COUNT(...)>n Finds documents where the search term is mentioned at least "n" times."n" may be any number (e.g., COUNT(gear)>8).
NEAR(..., ..., ) Finds documents with both search terms in any word order, permitting "n" words as a maximum distance between them. Best choose between 15 and 30 (e.g., NEAR(recruit, professionals, 20)).
* Finds documents with the search term in word versions or composites. The star * marks whether you wish them BEFORE, BEHIND, or BEFORE and BEHIND the search term (e.g., lightweight*, *lightweight, *lightweight*).
? Finds documents with the search termn in different spellings."?" allows only one character (e.g., organi?ation).
& + - Special characters are understood as AND (e.g., Miller Bros. & Sons).

You can use operators in your search query to narrow down your results even more.

Tap the operator, or hover the mouse pointer over it, to read more about how it works.